drugset / Trial / NCT03291990
5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
NaSingle-groupOpen-labelOther
Summary
This investigation is not only to develop an improved radiation/temozolomide approach, but also develop a regimen with potential to form the basis of better combined therapy with immune based treatments.
Timeline
- Start
- 2017-10-18
- Primary completion
- 2020-08-19
- Completion
- 2020-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | — | — |